David Cella1, Jin-Shei Lai2, Sally E Jensen2, Christopher Christodoulou3, Doerte U Junghaenel4, Bryce B Reeve5, Arthur A Stone4. 1. Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, 633 N. St. Clair, 19th Floor, Chicago, IL, USA. Electronic address: d-cella@northwestern.edu. 2. Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, 633 N. St. Clair, 19th Floor, Chicago, IL, USA. 3. Department of Neurology, Health Science Center T12-045, Stony Brook University, Stony Brook, NY 11794-8121, USA. 4. University of Southern California, USC Dornsife Center for Self-Report Science, 635 Downey Way, Los Angeles, CA 90089-3332, USA. 5. Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, 1101D McGavran-Greenberg Hall, CB #7411, Chapel Hill, NC 27599-7411, USA.
Abstract
OBJECTIVE: To evaluate the comparability and responsiveness of Patient-Reported Outcomes Measurement Information System (PROMIS) fatigue item bank across six chronic conditions. STUDY DESIGN AND SETTING: Individuals (n = 1,430) with chronic obstructive pulmonary disease (n = 125), chronic heart failure (n = 60), chronic back pain (n = 218), major depressive disorder (n = 196), rheumatoid arthritis (n = 521), and cancer (n = 310) completed assessments from the PROMIS fatigue item bank at baseline and a clinically relevant follow-up. The cancer and arthritis samples were followed in observational studies; the other four groups were enrolled immediately before a planned clinical intervention. All participants completed global ratings of change at follow-up. Linear mixed-effects models and standardized response means were estimated to examine clinical validity and responsiveness to change. RESULTS: All patient groups reported more fatigue than the general population (range = 0.2-1.29 standard deviation worse). The four clinical groups with pretreatment baseline data experienced significant improvement in fatigue at follow-up (effect size range = 0.25-0.91). Individuals reporting better overall health usually experienced larger fatigue changes than those reporting worse overall health. CONCLUSION: The results support the PROMIS fatigue measures's responsiveness to change in six different chronic conditions. In addition, these results support the ability of the PROMIS fatigue measures to compare differences in fatigue across a range of chronic conditions, thereby enabling comparative effectiveness research.
OBJECTIVE: To evaluate the comparability and responsiveness of Patient-Reported Outcomes Measurement Information System (PROMIS) fatigue item bank across six chronic conditions. STUDY DESIGN AND SETTING: Individuals (n = 1,430) with chronic obstructive pulmonary disease (n = 125), chronic heart failure (n = 60), chronic back pain (n = 218), major depressive disorder (n = 196), rheumatoid arthritis (n = 521), and cancer (n = 310) completed assessments from the PROMIS fatigue item bank at baseline and a clinically relevant follow-up. The cancer and arthritis samples were followed in observational studies; the other four groups were enrolled immediately before a planned clinical intervention. All participants completed global ratings of change at follow-up. Linear mixed-effects models and standardized response means were estimated to examine clinical validity and responsiveness to change. RESULTS: All patient groups reported more fatigue than the general population (range = 0.2-1.29 standard deviation worse). The four clinical groups with pretreatment baseline data experienced significant improvement in fatigue at follow-up (effect size range = 0.25-0.91). Individuals reporting better overall health usually experienced larger fatigue changes than those reporting worse overall health. CONCLUSION: The results support the PROMIS fatigue measures's responsiveness to change in six different chronic conditions. In addition, these results support the ability of the PROMIS fatigue measures to compare differences in fatigue across a range of chronic conditions, thereby enabling comparative effectiveness research.
Authors: Ann M Berger; Amy Pickar Abernethy; Ashley Atkinson; Andrea M Barsevick; William S Breitbart; David Cella; Bernadine Cimprich; Charles Cleeland; Mario A Eisenberger; Carmen P Escalante; Paul B Jacobsen; Phyllis Kaldor; Jennifer A Ligibel; Barbara A Murphy; Tracey O'Connor; William F Pirl; Eve Rodler; Hope S Rugo; Jay Thomas; Lynne I Wagner Journal: J Natl Compr Canc Netw Date: 2010-08 Impact factor: 11.908
Authors: Sheila M Marcus; Elizabeth A Young; Kevin B Kerber; Susan Kornstein; Amy H Farabaugh; Jeff Mitchell; Stephen R Wisniewski; G K Balasubramani; Madhukar H Trivedi; A John Rush Journal: J Affect Disord Date: 2005-08 Impact factor: 4.839
Authors: Marina de Góes Salvetti; Cibele Andrucioli de Mattos Pimenta; Patrícia Emília Braga; Michael McGillion Journal: Rev Lat Am Enfermagem Date: 2013 Jan-Feb
Authors: Karon F Cook; Sally E Jensen; Benjamin D Schalet; Jennifer L Beaumont; Dagmar Amtmann; Susan Czajkowski; Darren A Dewalt; James F Fries; Paul A Pilkonis; Bryce B Reeve; Arthur A Stone; Kevin P Weinfurt; David Cella Journal: J Clin Epidemiol Date: 2016-03-04 Impact factor: 6.437
Authors: Dennis A Revicki; David Cella; Ron D Hays; Jeff A Sloan; William R Lenderking; Neil K Aaronson Journal: Health Qual Life Outcomes Date: 2006-09-27 Impact factor: 3.186
Authors: S J Bartlett; A K Gutierrez; A Butanis; V P Bykerk; J R Curtis; S Ginsberg; A L Leong; A Lyddiatt; W B Nowell; A M Orbai; K C Smith; C O Bingham Journal: Qual Life Res Date: 2018-05-24 Impact factor: 4.147
Authors: David M Condon; Robert Chapman; Sara Shaunfield; Michael A Kallen; Jennifer L Beaumont; Daniel Eek; Debanjali Mitra; Katy L Benjamin; Kelly McQuarrie; Jamae Liu; James W Shaw; Allison Martin Nguyen; Karen Keating; David Cella Journal: Qual Life Res Date: 2019-11-07 Impact factor: 4.147
Authors: Fengmin Zhao; David Cella; Judith Manola; Robert S DiPaola; Lynne I Wagner; Naomi S B Haas Journal: Support Care Cancer Date: 2017-12-23 Impact factor: 3.603
Authors: Felix Fischer; Chris Gibbons; Joël Coste; Jose M Valderas; Matthias Rose; Alain Leplège Journal: Qual Life Res Date: 2018-01-19 Impact factor: 4.147
Authors: Diane Flynn; Linda H Eaton; Dale J Langford; Nicholas Ieronimakis; Honor McQuinn; Richard O Burney; Samuel L Holmes; Ardith Z Doorenbos Journal: Contemp Clin Trials Date: 2018-08-24 Impact factor: 2.226
Authors: Meghan Reading Turchioe; Lisa V Grossman; Dawon Baik; Christopher S Lee; Mathew S Maurer; Parag Goyal; Monika M Safford; Ruth M Masterson Creber Journal: J Am Geriatr Soc Date: 2020-03-10 Impact factor: 5.562